Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Aclarion, Inc.

ACONWNASDAQ
Healthcare
Medical - Healthcare Information Services
$0.04
$0.00(0.00%)
U.S. Market is Open • 12:30

Aclarion, Inc. Fundamental Analysis

Aclarion, Inc. (ACONW) shows weak financial fundamentals with a PE ratio of -0.20, profit margin of -108.68%, and ROE of -67.53%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position51930.89%
PEG Ratio-0.00
Current Ratio17.01

Areas of Concern

ROE-67.53%
Operating Margin-101.74%
We analyze ACONW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -10256.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-10256.5/100

We analyze ACONW's fundamental strength across five key dimensions:

Efficiency Score

Weak

ACONW struggles to generate sufficient returns from assets.

ROA > 10%
-55.56%

Valuation Score

Excellent

ACONW trades at attractive valuation levels.

PE < 25
-0.20
PEG Ratio < 2
-0.00

Growth Score

Weak

ACONW faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

ACONW maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
17.01

Profitability Score

Weak

ACONW struggles to sustain strong margins.

ROE > 15%
-6753.07%
Net Margin ≥ 15%
-108.68%
Positive Free Cash Flow
No

Key Financial Metrics

Is ACONW Expensive or Cheap?

P/E Ratio

ACONW trades at -0.20 times earnings. This suggests potential undervaluation.

-0.20

PEG Ratio

When adjusting for growth, ACONW's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Aclarion, Inc. at 0.12 times its book value. This may indicate undervaluation.

0.12

EV/EBITDA

Enterprise value stands at -1.80 times EBITDA. This is generally considered low.

-1.80

How Well Does ACONW Make Money?

Net Profit Margin

For every $100 in sales, Aclarion, Inc. keeps $-108.68 as profit after all expenses.

-108.68%

Operating Margin

Core operations generate -101.74 in profit for every $100 in revenue, before interest and taxes.

-101.74%

ROE

Management delivers $-67.53 in profit for every $100 of shareholder equity.

-67.53%

ROA

Aclarion, Inc. generates $-55.56 in profit for every $100 in assets, demonstrating efficient asset deployment.

-55.56%

Following the Money - Real Cash Generation

Operating Cash Flow

Aclarion, Inc. generates limited operating cash flow of $-6.43M, signaling weaker underlying cash strength.

$-6.43M

Free Cash Flow

Aclarion, Inc. generates weak or negative free cash flow of $-6.52M, restricting financial flexibility.

$-6.52M

FCF Per Share

Each share generates $-11.21 in free cash annually.

$-11.21

FCF Yield

ACONW converts -4.40% of its market value into free cash.

-4.40%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.20

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.12

vs 25 benchmark

P/S Ratio

Price to sales ratio

21.98

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

17.01

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.68

vs 25 benchmark

ROA

Return on assets percentage

-0.56

vs 25 benchmark

ROCE

Return on capital employed

-0.55

vs 25 benchmark

How ACONW Stacks Against Its Sector Peers

MetricACONW ValueSector AveragePerformance
P/E Ratio-0.2029.43 Better (Cheaper)
ROE-67.53%800.00% Weak
Net Margin-10867.85%-20145.00% (disorted) Weak
Debt/Equity0.000.30 Strong (Low Leverage)
Current Ratio17.014.64 Strong Liquidity
ROA-55.56%-17936.00% (disorted) Weak

ACONW outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Aclarion, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ